Home » Newsletters » BioWorld Asia

BioWorld Asia

June 21, 2000

View Archived Issues

Qiagen Acquiring Operon In Stock Deal Valued At $110M

EU Ministers Take Steps To Promote European Research

French Oppose Commission Directive On Biotech Patents

NsGene, Biogen Collaborate In Neublastin Deal Worth $20M

Kirkman Seeks Greater Role For BIA As He Assumes Top Position

Recap Of Deals, Financings Now Available From BioWorld

GPC Biotech, Karo Collaborate To Identify Novel Antibiotics

Commissioner Says Industry Brought GMO Flap On Itself

OECD Report To G8 Calls For Harmonization Of Regulations

Lorantis Completing First Round To Fund Program Around Notch

QBI Plans IPO As Biotech In Israel Gets Venture Boost

Other News To Note

Bioniche Identifies New Class Of Molecules Against Cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...